After more than 16 years at the helm, founder Klavs Esbjerg will hand over the CEO role at the end of 2025. Per Johansson, former CEO of KMD Group, will take over the position, while Klavs will remain a significant shareholder and continue as an active member of the Board of Directors, serving as a strategic advisory capacity to help guide Epista’s long-term vision and value.

Per Johansson

Per Johansson brings extensive experience in international scaling, strategic leadership, and software development. At KMD, he led a significant transformation and growth strategy. He now joins Epista to drive the company’s next global chapter.

“Life Sciences is one of the most exciting global growth markets, driven by rapid technological development and increasing demands for security, compliance, and efficiency. Epista is already a trusted partner and holds a strong position in this space. I look forward to building on the foundation created by Klavs and the team,” says Per Johansson.

‍